Creative Planning Novo Nordisk A S Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Novo Nordisk A S stock. As of the latest transaction made, Creative Planning holds 294,799 shares of NVO stock, worth $31.8 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

294,799

Previous 281,596 4.69%

Holding current value

$31.8 Million

Previous $40.2 Million 12.67%

% of portfolio

0.03%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$119.07 - $145.42 $1.57 Million - $1.92 Million	13,203 Added 4.69%	294,799 $35.1 Million
Q2 2024 Aug 15, 2024	BUY	$122.71 - $146.91 $2.8 Million - $3.36 Million	22,848 Added 8.83%	281,596 $40.2 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $4.23 Million - $5.63 Million	41,425 Added 19.06%	258,748 $33.2 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $2.44 Million - $2.93 Million	27,776 Added 14.65%	217,323 $22.5 Million
Q3 2023 Nov 16, 2023	BUY	$90.94 - $199.54 $9.25 Million - $20.3 Million	101,667 Added 115.69%	189,547 $17.2 Million
Q2 2023 Jul 21, 2023	BUY	$155.98 - $172.65 $1.45 Million - $1.61 Million	9,310 Added 11.85%	87,880 $14.2 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $490,452 - $589,772	3,706 Added 4.95%	78,570 $12.5 Million
Q4 2022 Feb 10, 2023	BUY	$102.55 - $135.33 $265,296 - $350,098	2,587 Added 3.58%	74,864 $10.1 Million
Q3 2022 Nov 03, 2022	BUY	$95.28 - $116.93 $522,610 - $641,361	5,485 Added 8.21%	72,277 $7.2 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $1.01 Million - $1.2 Million	9,813 Added 17.22%	66,792 $7.44 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $117,212 - $141,687	1,259 Added 2.26%	56,979 $6.33 Million
Q4 2021 Feb 11, 2022	SELL	$95.88 - $117.08 $319,759 - $390,461	-3,335 Reduced 5.65%	55,720 $6.24 Million
Q3 2021 Nov 10, 2021	SELL	$84.42 - $106.62 $493,772 - $623,620	-5,849 Reduced 9.01%	59,055 $5.67 Million
Q2 2021 Aug 04, 2021	SELL	$67.66 - $84.76 $1.81 Million - $2.27 Million	-26,739 Reduced 29.18%	64,904 $5.44 Million
Q1 2021 Apr 30, 2021	SELL	$67.06 - $75.82 $1.47 Million - $1.67 Million	-21,992 Reduced 19.35%	91,643 $6.18 Million
Q4 2020 Jan 29, 2021	BUY	$63.89 - $73.8 $5.47 Million - $6.32 Million	85,693 Added 306.68%	113,635 $7.94 Million
Q3 2020 Nov 05, 2020	BUY	$63.69 - $70.22 $303,992 - $335,160	4,773 Added 20.6%	27,942 $1.94 Million
Q2 2020 Jul 23, 2020	SELL	$58.54 - $67.94 $494,077 - $573,413	-8,440 Reduced 26.7%	23,169 $1.52 Million
Q1 2020 May 05, 2020	SELL	$49.46 - $64.78 $5,044 - $6,607	-102 Reduced 0.32%	31,609 $1.9 Million
Q4 2019 Jan 30, 2020	SELL	$49.86 - $58.26 $157,557 - $184,101	-3,160 Reduced 9.06%	31,711 $1.84 Million
Q3 2019 Nov 01, 2019	SELL	$47.54 - $53.43 $24,150 - $27,142	-508 Reduced 1.44%	34,871 $1.8 Million
Q2 2019 Jul 26, 2019	BUY	$46.79 - $52.47 $408,944 - $458,587	8,740 Added 32.81%	35,379 $1.81 Million
Q1 2019 Apr 24, 2019	SELL	$46.36 - $52.63 $456,136 - $517,826	-9,839 Reduced 26.97%	26,639 $1.39 Million
Q4 2018 Feb 01, 2019	SELL	$41.54 - $47.25 $153,490 - $174,588	-3,695 Reduced 9.2%	36,478 $1.68 Million
Q3 2018 Oct 25, 2018	SELL	$46.76 - $51.24 $42,411 - $46,474	-907 Reduced 2.21%	40,173 $1.89 Million
Q2 2018 Jul 20, 2018	BUY	$44.29 - $50.42 $108,599 - $123,629	2,452 Added 6.35%	41,080 $1.9 Million
Q1 2018 Apr 18, 2018	SELL	$48.49 - $58.14 $327,355 - $392,503	-6,751 Reduced 14.88%	38,628 $1.9 Million
Q4 2017 Jan 17, 2018	BUY	$47.53 - $53.73 $222,773 - $251,832	4,687 Added 11.52%	45,379 $2.44 Million
Q3 2017 Oct 17, 2017	BUY	$41.15 - $49.22 $1.67 Million - $2 Million	40,692	40,692 $1.96 Million

Others Institutions Holding NVO

# of Institutions

1,956

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $244B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Novo Nordisk A S Transaction History